Ionis Pharmaceuticals Stock In The News
| IONS Stock | USD 31.04 0.69 2.27% |
Our overall analysis of Ionis Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Ionis Pharmaceuticals. The specific impact of Ionis Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ionis Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ionis Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ionis Pharmaceuticals Backtesting and Ionis Pharmaceuticals Hype Analysis. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.
Ionis |
Ionis Pharmaceuticals Today Top News and Investor Outlook
Ionis Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ionis and other traded companies coverage with news coverage. We help investors stay connected with Ionis headlines for the 18th of February 2025 to make an informed investment decision based on correlating the impacts of news items on Ionis Stock performance. Please note that trading solely based on the Ionis Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ionis Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ionis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ionis Pharmaceuticals that are available to investors today. That information is available publicly through Ionis media outlets and privately through word of mouth or via Ionis internal channels. However, regardless of the origin, that massive amount of Ionis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ionis Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ionis Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ionis Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ionis Pharmaceuticals alpha.
Ionis Largest EPS Surprises
Earnings surprises can significantly impact Ionis Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-02-27 | 2017-12-31 | 0.01 | 0.02 | 0.01 | 100 | ||
2013-05-07 | 2013-03-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2009-08-06 | 2009-06-30 | -0.02 | -0.03 | -0.01 | 50 | ||
2018-05-04 | 2018-03-31 | -0.03 | -0.01 | 0.02 | 66 | ||
2017-05-09 | 2017-03-31 | 0.05 | 0.03 | -0.02 | 40 | ||
2016-11-09 | 2016-09-30 | 0.08 | 0.06 | -0.02 | 25 |
Ionis Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ionis Pharmaceuticals Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
14th of February 2025
Capital World Investors Acquires Significant Stake in Ionis Pharmaceuticals at gurufocus.com
11th of February 2025
Why Insiders Are Selling Ionis Pharmaceuticals, Inc. Recently at finance.yahoo.com
7th of February 2025
T. Rowe Price Investment Management, Inc. Expands Stake in Ionis Pharmaceuticals at gurufocus.com
4th of February 2025
Insider Sell Elizabeth Hougen Sells Shares of Ionis Pharmaceuticals Inc at gurufocus.com
31st of January 2025
Ionis stock slips as Novartis delays heart drug trial at seekingalpha.com
30th of January 2025
Acquisition by Bennett C Frank of 3607 shares of Ionis Pharmaceuticals subject to Rule 16b... at MacroaxisInsider
16th of January 2025
Disposition of 1029 shares by Baroldi Joseph of Ionis Pharmaceuticals at 32.7 subject to R... at thelincolnianonline.com
23rd of December 2024
PANTHERx Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA at finance.yahoo.com
6th of December 2024
Ionis Pharmaceuticals Down 4.5 percent Since Last Earnings Report Can It Rebound at finance.yahoo.com
Ionis Pharmaceuticals Investors Sentiment
The influence of Ionis Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ionis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ionis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ionis. The trend in average sentiment can be used to explain how an investor holding Ionis can time the market purely based on public headlines and social activities around Ionis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ionis Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ionis Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ionis Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ionis Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ionis Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ionis Pharmaceuticals' short interest history, or implied volatility extrapolated from Ionis Pharmaceuticals options trading.
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.